奥美拉唑碳酸氢钠胶囊FDA说明书.pdfVIP

HIGHLIGHTS OF PRESCRIBING INFORMATION Sodium content to be taken into consideration when administering to These highlights do not include all the information needed to use patients on a sodium-restricted diet ZEGERID® with Magnesium Hydroxide Chewable Tablets safely and Magnesium content increases risk of hypermagnesemia and magnesium effectively. See full prescribing information for ZEGERID with toxicity in neonates, elderly, and in patients with renal impairment or Magnesium Hydroxide Chewable Tablets. renal disease To be used with caution in patients with Bartter’s syndrome, ZEGERID with Magnesium Hydroxide (omeprazole/sodium hypokalemia, respiratory alkalosis, and problems with acid-base balance bicarbonate/magnesium hydroxide) Chewable Tablets because of its sodium bicarbonate content; long-term administration of Initial U.S. Approval: 2004 bicarbonate with calcium or milk can cause milk-alkali syndrome INDICATIONS AND USAGE ADVERSE REACTIONS ZEGERID with Magnesium Hydroxide Chewable Tablets is a proton pump Most common adverse reactions (incidence ≥ 2%) are: inhibitor indicated for: Headache, abdominal pain, nausea, diarrhea, vomiting, and flatulence (6) • Treatment of duodenal ulcer (1.1) To report SUSPECTED A